Old Web
English
Sign In
Acemap
>
authorDetail
>
Natasa Rajicic
Natasa Rajicic
Cytel
Medicine
in patient
Tipifarnib
Head and neck squamous-cell carcinoma
first line
2
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The AIM-HN and SEQ-HN study: A pivotal study evaluating the efficacy of tipifarnib in patients with head and neck squamous cell carcinoma (HNSCC) with hras mutations (AIM-HN) and the impact of hras mutations on response to first line systemic therapies for HNSCC (SEQ-HN).
2020
Journal of Clinical Oncology
Robert I. Haddad
Kevin J. Harrington
Lisa Licitra
Amanda Psyrri
Nabil F. Saba
Natasa Rajicic
Binaifer R. Balsara
Michael R. Kurman
Catherine Rose Scholz
Antonio Gualberto
Alan Loh Ho
Show All
Source
Cite
Save
Citations (1)
SUN-LB079 Acrostudy - Safety And Treatment Outcomes In 2221 Patients With Acromegaly Treated With Pegvisomant: Real World Experience
2019
Journal of the Endocrine Society
Michael Wajnrajch
Roy Gomez
Judith Hey-Hadavi
Nicky Kelepouris
Joli van der Lans
Cecilia Camacho-Hübner
Jose Cara
Natasa Rajicic
Srinivas Rao Valluri
Maria Fleseriu
Roberto Salvatori
Thierry Brue
Ezio Ghigo
Andrew Palladino
Show All
Source
Cite
Save
Citations (0)
1